What it sells
AI-native pharma marketing.
Business model breakdown
Buyer: who owns the budget?
UnverifiedPharma brand and marketing leads (testimonial from a Rare Disease Marketing Director) replacing their agency of record.
Trigger: what makes them buy now?
Compliant HCP emails took brand teams up to 3 months to produce; with Solstice it can take less than a day.
Workflow: what inputs become what output?
Build a brand library from approved assets; submit briefs in dashboard; AI generates and fact-checks assets within 24 hours; client feedback; auto-submit to Veeva MLR review; deploy and measure.
Economics: what it saves and how it charges
Positions as AI-native agency replacing traditional agencies of record, claiming faster content and more content than AORs.
Distribution: how it reaches customers
Engagement-team led agency-style service ('Work with us').
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-05-28 | — | $21M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.